Safety Trial of Antimicrobial Therapy and Precision Radiation Therapy in Patients With Oligoprogressive Non-small Cell Lung Cancer
Clinical trial NCT03546829 · RECRUITING
Trial details
- NCT number
- NCT03546829
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-05
- Primary completion
- 2027-12-31
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.